Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.900
0.00 (0.00%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $676.37 million as of September 3, 2026. Its market cap has decreased by -43.59% in one year.
Market Cap
676.37M
Enterprise Value
688.32M
1-Year Change
-43.59%
Ranking
Category
Stock Price
$1.90
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $676.37M, a decrease of -92.64%. That is a compound annual growth rate of -41.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 676.37M | -40.50% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacira BioSciences | 1.06B |
| Amphastar Pharmaceuticals | 976.67M |
| Glass House Brands | 800.12M |
| Collegium Pharmaceutical | 781.33M |
| Ironwood Pharmaceuticals | 705.57M |
| Aquestive Therapeutics | 657.68M |
| Tilray Brands | 610.26M |
| Evolus | 599.74M |